Rina Rosin-Arbesfeld

Years Active: 2019-2023
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Amnon Wittenstein, Michal Caspi, Ido Rippin, Orna Elroy-Stein, Hagit Eldar-Finkelman, Sven Thoms, Rina Rosin-Arbesfeld
Nonsense mutation suppression is enhanced by targeting different stages of the protein synthesis process. PLoS biology 21 (11) (2023)
Alessio David Nahmad, Cicera R Lazzarotto, Natalie Zelikson, Talia Kustin, Mary Tenuta, Deli Huang, Inbal Reuveni, Daniel Nataf, Yuval Raviv, Miriam Horovitz-Fried, Iris Dotan, Yaron Carmi, Rina Rosin-Arbesfeld, David Nemazee, James E Voss, Adi Stern, Shengdar Q Tsai, Adi Barzel
In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice. Nature biotechnology 40 (8) (2022)
Tamar Evron, Michal Caspi, Michal Kazelnik, Yarden Shor-Nareznoy, Shir Armoza-Eilat, Revital Kariv, Zohar Manber, Ran Elkon, Ella H Sklan, Rina Rosin-Arbesfeld
A CRISPR knockout screen reveals new regulators of canonical Wnt signaling. Oncogenesis 10 (9) (2021)
Revital Kariv, Michal Caspi, Naomi Fliss-Isakov, Yamit Shorer, Yarden Shor, Guy Rosner, Eli Brazowski, Gil Beer, Shlomi Cohen, Rina Rosin-Arbesfeld
Resorting the function of the colorectal cancer gatekeeper adenomatous polyposis coli. International journal of cancer 146 (4) (2019)

Rina Rosin-Arbesfeld.css-eqlu8i{font-size:small;padding-left:4px;}